Sino Biological,Inc. (SHE:301047)

China · Delayed Price · Currency is CNY

71.30

+1.46 (2.09%)

At close: Mar 6, 2026

11.49% (1Y)

Market Cap	8.67B +14.2%
Revenue (ttm)	660.17M +3.9%
Net Income	132.79M -13.9%
EPS	1.08 -10.8%
Shares Out	121.64M
PE Ratio	66.32
Forward PE	59.92
Dividend	4.00 (5.61%)
Ex-Dividend Date	Sep 22, 2025

Volume	667,150
Average Volume	804,321
Open	69.84
Previous Close	69.84
Day's Range	69.41 - 71.43
52-Week Range	57.40 - 85.00
Beta	1.02
RSI	43.33
Earnings Date	Apr 14, 2026

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine dev... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 1,021

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301047

Full Company Profile

Financial Performance

In 2024, Sino Biological,Inc.'s revenue was 613.67 million, a decrease of -5.06% compared to the previous year's 646.39 million. Earnings were 121.93 million, a decrease of -53.13%.

Financial Statements